Pharmacology, Toxicology and Pharmaceutical Science
Opiate
100%
Human
75%
Cannabidiol
58%
Oxycodone
54%
Placebo
51%
Drug
47%
Cannabis
45%
Dronabinol
41%
Cannabinoid
39%
Triazolam
35%
Blindness
29%
Pharmacodynamics
29%
Progesterone
29%
Normal Human
29%
Analgesic Agent
25%
Pharmacokinetics
25%
Clinical Trial
25%
Tramadol
23%
Dexamphetamine
23%
Enalapril Maleate
23%
Tetrahydrocannabinol
23%
Diseases
17%
Placebo-Controlled Study
16%
Cannabis Sativa
16%
Emergency
14%
Acetylcysteine
12%
Stimulant
12%
Opiate Agonist
12%
Methamphetamine
11%
Toxic Injury
11%
Buprenorphine
11%
Diethylstilbestrol
11%
Nicotine
11%
Quinine
11%
Acetazolamide
11%
Oxymorphone
11%
Kappa Antagonists
11%
Randomized Controlled Trial
11%
Naloxone
11%
Tracer
11%
Tobacco Dependence
9%
Pain
9%
Buprenorphine Plus Naloxone
8%
Miosis
6%
Behavioral Effect
5%
Opiate Addiction
5%
Receptor
5%
Codeine
5%
Complication
5%
Experimental Pain
5%
Neuroscience
Opioid
59%
Cannabis
53%
Placebo
44%
Oxycodone
24%
Amphetamine
23%
Cannabidiol
23%
Oxymorphone
23%
Diethylstilbestrol
23%
Agonist
22%
Tetrahydrocannabinol
16%
Progesterone
13%
Behavior (Neuroscience)
13%
Drug Abuse
12%
Acetylcysteine
12%
Tramadol
11%
Triazolam
11%
Receptor Antagonist
11%
Nicotine
11%
Randomized Controlled Trial
11%
Κ-opioid receptor
11%
Kappa Opiate Receptor
11%
Methamphetamine
11%
Tobacco Dependence
9%
Medicine and Dentistry
Opiate
23%
Placebo
17%
Abuse
15%
Evaluation Study
13%
Human
13%
Diseases
12%
Tetrahydrocannabinol
11%
Methamphetamine
11%
Estradiol
11%
Dextroamphetamine
11%
Cannabidiol
11%
Acetylcysteine
11%
Cannabis Use
11%
Discriminative Stimulus
11%
Adult
11%
Premenopause
11%
Opiate Agonist
11%
Quantitative Analysis
11%
Drug Use
11%
Chemotherapeutic Agent
11%
Drug
11%